Loading…
Tuesday September 29, 2026 16:00 - 17:00 CEST
Women specificities in healthcare are gaining importance due to the higher socieconomical status in developed countries and insights from research highlighting sex and gender disparities in the development, prevention and treatment of diseases.

As an example, cardiovascular disease remains the leading cause of death among women in the EU, yet it is still under-researched, frequently misdiagnosed, and often undertreated. Another case is that of migraine, an under-recognized women's health problem. Its high prevalence in women, the gender gap in diagnosis, and diagnostic delays have a significant economic, occupational, and social impact impacting career paths, leisure time, social life, and reproductive decisions.

Understanding women's health requires moving beyond a "one-size-fits-all" medical model to one that recognizes the profound impact of sex and gender on health outcomes and considers the differential needs in prevention and treatment. In parallel, there is a growing high-tech market delivering new healthcare products and services specifically designed for women, the so-called femtech sector, with innovations specifically designed for women’s wellness or care related to diagnostic devices, wearable sensors, etc. This panel will analyze this healthcare paradigm change and the related technological innovations as well as the integration of these aspects into routine clinical workflows by multidisciplinary experts including a cardiologist with expertise in digital health and AI, pharma and femtech companies.

A call to political action: propose a national health plan with a gender perspective, more training in primary care, more sex-disaggregated research, and greater institutional recognition.


Speakers
avatar for María Amparo Valladares López

María Amparo Valladares López

Market Access Value Proposition & Government Affairs Lead, AbbVie

avatar for Eva Colás Ortega

Eva Colás Ortega

CSO & Founder, Mimark
I am the principal investigator of the Biomedical Research Group in Gynecology, where I lead the translational research group. My research focuses on providing solutions to unmet clinical needs in gynecology, primarily in endometrial cancer and endometriosis. We work on biomarker... Read More →
avatar for Marina Pollán

Marina Pollán

Director, Instituto de Salud Carlos III (ISCIII)
Marina Pollán holds a degree in Medicine from the University of Salamanca and is a specialist in Preventive Medicine and Public Health. She also studied at the Johns Hopkins School of Public Health (Baltimore, USA) and the Karolinska Institute (Stockholm, Sweden), and received the... Read More →
AV

Ane Vitoria

Scientific Advisory Board, Qassay Diagnostics/Welleo

avatar for Iván Macía Oliver

Iván Macía Oliver

Director of Digital Health & Biomedical Technologies, Vicomtech
- Vicomtech - Director of Digital Health and Biomedical Technologies (abbreviated Director of Health): This is my main role and the one that pays me. The biggest implication here is that I lead CARAMEL, a Horizon Europe project on Personalized Prevention in Women's Cardiovascular... Read More →
avatar for Carlos Escobar Cervantes

Carlos Escobar Cervantes

Cardiologist and co-founder Cofounder SAMIRA DTx, Hospital La Paz
Education: Bachelor of Medicine and Surgery from the Autonomous University of Madrid (1993-99). Doctor of Medicine from the University of Alcalá, awarded summa cum laude by unanimous decision (2007).

Professional Experience: Attending Physician in Cardiology at the Ramón y Cajal University Hospital in Madrid from 2006 to February 2008. Attending Physician in Cardiology at the Infanta Sofía University Hospital in San Sebastián de los Reyes, Madrid, from February 2008 to May... Read More →
Tuesday September 29, 2026 16:00 - 17:00 CEST
2 Dorotea Barnés room

Sign up or log in to save this to your schedule, view media, leave feedback and see who's attending!

Share Modal

Share this link via

Or copy link